
Merck wins EU nod for rare lung disease drug Winrevair (NYSE:MRK)
Sundry Photography/iStock Editorial through Getty Images Merck (NYSE:MRK) has acquired approval from the European Commission for its drug Winrevair (sotatercept), for use together…

Sundry Photography/iStock Editorial through Getty Images Merck (NYSE:MRK) has acquired approval from the European Commission for its drug Winrevair (sotatercept), for use together…

Sundry Photography/iStock Editorial by way of Getty Images Merck (NYSE:MRK) has obtained approval from the European Commission for its drug Winrevair (sotatercept), for…

Sundry Photography/iStock Editorial by way of Getty Images Merck (NYSE:MRK) has obtained approval from the European Commission for its drug Winrevair (sotatercept), for…